Main > ONCOLOGY (**) > Breast Cancer>HER2+>MET *** > Treatment > USA. G. Brand TrastuzuMAb

---

USA. G. Brand TrastuzuMAb's subsections
Approved Indications>
Companion Diagnostics>
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 20
Patent>UpDate: 2007. 01.16
Patent>USA Expiration: 2014. 08.05
TradeMark
TradeMark Web-Site

USA. G. Brand TrastuzuMAb's products
This section has no products